Delivery Order SPE2DB22D2007-SPE2DB24FJ2TU

Award Date 5/22/24
Potential Completion Date 5/23/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,200.54, is for the delivery of Lumigan 0.01% eye drops (5 ml) and has an ultimate completion date of April 12, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lumigan 0.01% eye drops, a prescription ophthalmic medication. The $1,260.78 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through December 20, 2022. This award is a task order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.89 firm fixed-price delivery order is for the supply of Lumigan 0.01% eye drops, a specialty ophthalmic medication. The contract, which has a completion date of June 16, 2023, is not designated under any set-aside program. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is for $2,173.20 and was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of Lumigan 0.01% eye drops in 5ml quantities. This is a firm fixed price delivery order contract with a performance period through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,569.94, is for the delivery of Lumigan 0.01% eye drops in a 5 ml size. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This contract award, with a ceiling value of $1,466.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the delivery of Lumigan 0.01% eye drops. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,284.09 for the supply of Lumigan 0.01% eye drops. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 1, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Lumigan 0.01% eye drops to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,747.98 and was awarded on January 20, 2022, with a completion date of January 21, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of LUMIGAN 0.01% eye drops. The $1,307.16 firm-fixed-price contract has an ultimate completion date of April 11, 2023. This contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a wide range of...
This federal contract award is for the delivery of 4564793430 LUMIGAN 0.01% eye drops, 2.5ML in volume, to the Defense Logistics Agency (DLA). The $14,705.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 3, 2024. It has a completion date of June 4, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ2TU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Lumigan 0.01% eye drops in 2.5 milliliter containers. The contract, valued at $2,693.73, is a firm fixed-price delivery order with a period of performance through May 23, 2024.

Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This specific award for Lumigan eye drops is likely a call order or delivery order placed against that IDC. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 8/21/24, 6:25 PM